Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 4Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 1663Neoplasms, Plasma Cell 415Lymphoma, Non-Hodgkin 311Lymphoma 283Hodgkin Disease 281Leukemia, Lymphocytic, Chronic, B-Cell 274Precursor Cell Lymphoblastic Leukemia-Lymphoma 246Leukemia, Myeloid, Acute 223Leukemia 220Lymphoma, Mantle-Cell 196Lymphoma, Large B-Cell, Diffuse 196Lymphoma, Follicular 196Myelodysplastic Syndromes 194Recurrence 185Lymphoma, B-Cell, Marginal Zone 178Burkitt Lymphoma 172Lymphoma, Large-Cell, Immunoblastic 161Myeloproliferative Disorders 146Leukemia, Myeloid, Chronic-Phase 134Leukemia, Myeloid, Accelerated Phase 122Primary Myelofibrosis 121Immunoglobulin Light-chain Amyloidosis 120Waldenstrom Macroglobulinemia 119Lymphoma, T-Cell, Cutaneous 119Blast Crisis 114Leukemia, Myelomonocytic, Chronic 105Sezary Syndrome 100Mycosis Fungoides 100Neoplasms 97Leukemia, Hairy Cell 95

Interventions

Lenalidomide 2Dexamethasone 2ixazomib 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × POEMS Syndrome × Plasma cell × Clear all
NCT02921893 2025-02-12

Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome

Mayo Clinic

Phase EARLY_PHASE1 Completed
21 enrolled
Plasma cell

Plasmacytoma, POEMS Syndrome

NCT01816620 2017-04-25

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

Peking Union Medical College Hospital

Phase 2 Completed
41 enrolled
Plasma cell

POEMS Syndrome, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡